NewsRx

Search our medical news database

Chemicals

Nano Chemical Systems Announces New Strategic Direction

Published in Medical Patent Law Weekly, November 7th, 2007

Nano Chemical Systems Holdings, Inc. (Pink Sheets:NCSH), ("Nanochem" or "The Company") announces that it has reached an agreement with Dr. Mathew Zuckerman for the return of common stock in exchange for the release of any rights to certain patents that Dr. Zuckerman may have assigned or developed with The Company. The Company is now aggressively pursuing a new strategic direction which will be based on an acquisition strategy that will create tremendous shareholder value.

"We wish Dr. Zuckerman well as he pursues other opportunities," stated Alex H. Edwards III, Nanochem's CEO. "This is the final positioning that needed to take place in order to achieve our acquisition...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook